How do you select patients with solid tumors that are appropriate for NGS? Is it just for patients who present with cancer? For patients under treatment? For assessment of tumors in relapsed patients?

How do you select patients with solid tumors that are appropriate for NGS? Is it just for patients who present with cancer? For patients under treatment? For assessment of tumors in relapsed patients?

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment? For assessment of tumors in patients who have relapsed?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea